V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20218010 | 20168797 | 1.71 | 64 | Palliative (P) | 2017-04-13 | 2017-07-07 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100660882 |
| 20218023 | 20168798 | 1.81 | 61 | Neo-adjuvant (N) | 2017-08-28 | 2017-09-27 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101603957 |
| 20218028 | 20168799 | 1.75 | 62.7 | Palliative (P) | 2018-07-06 | 2018-07-07 | Trial Unspecified | N | N | TRIAL | 101205596 |
| 20218032 | 20168800 | 1.83 | 75 | Palliative (P) | 2017-12-05 | 2017-12-07 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101217736 |
| 20218033 | 20168801 | 0 | 69.6 | Palliative (P) | 2018-06-20 | 2018-06-26 | Trial Unspecified | 02 | N | TRIAL | 101396744 |
| 20218052 | 20168802 | 1.75 | 47.6 | null | 2018-06-10 | 2018-06-10 | IRINOTECAN + MDG + PANITUMUMAB | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100032040 |
| 20218055 | 20168803 | 1.57 | 78.7 | Palliative (P) | 2019-07-07 | 2019-07-15 | Trial Unspecified | N | N | TRIAL | 101065960 |
| 20218090 | 20168804 | 1.76 | 77 | Palliative (P) | 2018-04-22 | 2018-05-12 | Sorafenib | 02 | N | SORAFENIB | 101088650 |
| 20218094 | 20168805 | 0 | 119.8 | Palliative (P) | 2017-10-18 | 2017-10-18 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 101574937 |
| 20218099 | 20168806 | 1.78 | 65 | Palliative (P) | 2018-12-08 | 2018-12-24 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + IRINOTECAN + MDG | 100603716 |
| 20218110 | 20168807 | 1.66 | 58.2 | Palliative (P) | 2019-09-22 | 2019-10-05 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101103757 |
| 20218111 | 20168808 | 0 | 83 | null | 2017-01-19 | 2017-01-29 | Capecitabine 35days + RT | 99 | null | CAPECITABINE + RT | 100856685 |
| 20218112 | 20168809 | 1.75 | 88.6 | Palliative (P) | 2020-03-01 | 2020-03-19 | EOX | 2 | Y | CETUXIMAB + IRINOTECAN + MDG | 101572820 |
| 20218115 | 20168810 | 1.51 | 83.8 | Palliative (P) | 2020-03-24 | 2020-04-06 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100221793 |
| 20218118 | 20168811 | 1.7 | 71.8 | null | 2019-03-10 | 2019-03-17 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100266890 |
| 20218154 | 20168812 | 1.6 | 83.1 | Palliative (P) | 2017-01-25 | 2017-01-25 | Capecitabine 35days + RT | 02 | Y | CAPECITABINE + RT | 100750336 |
| 20218161 | 20168813 | 1.74 | 99.7 | Palliative (P) | 2019-10-26 | 2019-11-16 | CAPECITABINE + RT | 99 | N | CAPECITABINE + RT | 100382991 |
| 20218164 | 20168814 | 1.6 | 76 | Palliative (P) | 2018-12-09 | 2018-12-09 | Sorafenib | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100218812 |
| 20218195 | 20168815 | 1.66 | 74.3 | Palliative (P) | 2016-09-06 | 2016-09-27 | EOX | N | N | EOX | 101728248 |
| 20218204 | 20168816 | 1.71 | 52 | Palliative (P) | 2018-08-06 | 2019-04-18 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100223862 |
| 20218215 | 20168817 | 1.66 | 64.1 | Palliative (P) | 2019-07-15 | 2020-03-13 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100808239 |
| 20218265 | 20168818 | 1.6 | 52.9 | Disease modification (D) | 2016-11-05 | 2017-01-06 | Capecitabine 42days + RT | N | N | CAPECITABINE + RT | 100272965 |
| 20218273 | 20168819 | 1.72 | 53.2 | Palliative (P) | 2021-05-27 | 2021-11-03 | EOX | 99 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101170746 |
| 20218276 | 20168820 | 0 | 64.4 | Palliative (P) | 2016-11-04 | 2016-11-19 | EOX | 2 | N | EOX | 101284561 |
| 20218280 | 20168821 | 1.67 | 59.6 | Curative (C) | 2020-03-25 | 2020-05-19 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100501565 |
| 20218285 | 20168822 | 1.82 | 66 | null | 2018-09-17 | 2018-11-26 | EOX | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101136723 |
| 20218293 | 20168823 | 1.56 | 62 | Curative (C) | 2017-01-14 | 2017-04-24 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100077366 |
| 20218294 | 20168824 | 1.84 | 73.7 | null | 2019-06-22 | 2019-07-15 | EOX | 02 | null | EOX | 100154491 |
| 20218307 | 20168825 | 1.57 | 87 | null | 2019-04-25 | 2019-10-07 | Capecitabine 35days + RT | 1 | null | TRIAL | 101033266 |
| 20218310 | 20168826 | 1.67 | 78 | Palliative (P) | 2016-10-12 | 2016-10-27 | EOX | 02 | Y | EOX | 100196506 |
| 20218315 | 20168827 | 1.7 | 83 | null | 2019-06-09 | 2019-07-26 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101649157 |
| 20218327 | 20168828 | 1.92 | 62.4 | null | 2019-01-31 | 2019-03-11 | Trial Unspecified | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100002628 |
| 20218329 | 20168829 | 1.79 | 70.6 | Palliative (P) | 2020-01-26 | 2020-01-26 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101197117 |
| 20218347 | 20168830 | 1.7 | 88.4 | Curative (C) | 2017-02-18 | 2018-08-26 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100864318 |
| 20218349 | 20168831 | 1.75 | 65 | Palliative (P) | 2016-06-16 | 2016-06-27 | EOX | 02 | Y | SORAFENIB | 101732987 |
| 20218359 | 20168832 | 1.71 | 85 | Adjuvant (A) | 2021-04-22 | 2022-01-17 | CAPECITABINE + RT | 01 | N | CAPECITABINE + RT | 101838276 |
| 20218363 | 20168833 | null | null | Curative (C) | null | 2018-05-08 | EOX | Y | null | TRIAL | 100606881 |
| 20218377 | 20168834 | 1.53 | 69.2 | Palliative (P) | 2018-05-15 | 2018-07-29 | EOX | 2 | N | EOX | 101100610 |
| 20218391 | 20168835 | 1.74 | 89.5 | Palliative (P) | 2020-01-14 | 2020-01-15 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100529703 |
| 20218393 | 20168836 | 1.57 | 71.2 | Palliative (P) | 2020-02-27 | 2020-03-08 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100876087 |
| 20218425 | 20168837 | 1.75 | 59.8 | Palliative (P) | 2019-03-23 | 2019-03-25 | EOX | 99 | N | CETUXIMAB + IRINOTECAN + MDG | 101665187 |
| 20218442 | 20168838 | 1.69 | 71 | null | 2020-05-05 | 2020-05-23 | EOX | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 100106734 |
| 20218459 | 20168839 | 1.72 | 61 | Palliative (P) | 2019-03-06 | 2019-03-06 | EOX | 02 | null | EOX | 100642056 |
| 20218469 | 20168840 | 1.56 | null | Palliative (P) | 2017-12-19 | 2019-11-05 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101686585 |
| 20218484 | 20168841 | 1.76 | 79.8 | Palliative (P) | 2018-10-27 | 2018-10-29 | Sorafenib | 02 | N | SORAFENIB | 100819810 |
| 20218488 | 20168842 | 1.75 | 70.6 | Neo-adjuvant (N) | 2017-03-23 | 2017-03-26 | Trial Unspecified | N | Y | TRIAL | 100739894 |
| 20218491 | 20168843 | 1.71 | 48.6 | Palliative (P) | 2022-01-11 | 2022-01-30 | EOX | 02 | N | EOX | 101366781 |
| 20218493 | 20168844 | 1.62 | 86.6 | Curative (C) | 2019-01-17 | 2019-02-19 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100056429 |
| 20218500 | 20168845 | 1.7 | 62.8 | null | 2018-10-07 | 2018-10-10 | Trial Unspecified | 02 | null | TRIAL | 101076279 |
| 20218510 | 20168846 | 0 | 54.8 | Palliative (P) | 2017-10-22 | 2017-11-15 | EOX | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100314820 |